Stay updated on Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial
Sign up to get notified when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.

Latest updates to the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now indicates recruitment status explicitly and adds user guidance sections along with an updated header and a revision note, clarifying how to read the study record and how to join the study.SummaryDifference0.4%

- Check17 days agoChange DetectedRevision: v3.5.5 was added, replacing the previous v3.5.4 on the page. This appears to be an administrative update to the page version and does not modify the study data or user-facing content.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision: v3.5.4 was added and the previous Revision: v3.5.3 was removed, updating the page's version metadata.SummaryDifference0.1%

- Check61 days agoChange DetectedThis update corresponds to the study’s **results being posted (2026-04-24)** and revises/defines key **outcome measure details**—notably the timing and definitions of endpoints such as **time to hospital readmission or death (all-cause and respiratory-cause)**, **treatment failure**, and counts of hospital readmissions and exacerbations over the **48-week** period. It also updates the specification of several measured patient outcomes (e.g., questionnaire-based health status scales such as eMRC/WEMWBS/SPPB/LCADL, oxygen/inflammatory marker outcomes, and continuous measures including temperature and heart rate across the follow-up window).SummaryDifference5%

- Check68 days agoChange DetectedRevision updated from v3.0.0 to v3.5.2.SummaryDifference0.1%

- Check97 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 in the Study Plan.SummaryDifference0.1%

Stay in the know with updates to Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mepolizumab for COPD Hospital Eosinophilic Admissions Clinical Trial page.